IBM Stock Drops 2% — But Its AI Dev Platform Just Did Something Impressive

TLDR

• IBM updated its Bob software development platform with multi-agent capabilities, AI cost analytics, and pre-built enterprise workflows.
• A new feature called Bobalytics tracks AI consumption and resource allocation across development environments.
• Three premium packages were released targeting IBM Z mainframe, IBM i, and Java modernization use cases.
• IBM stock opened at $302.18 Thursday and is down around 2% on the day, with Q2 earnings due July 22.
• Analyst consensus is “Moderate Buy” with an average price target of $306.47; BofA has a $330 target with a Buy rating.

---

IBM rolled out a major update to its Bob software development platform on Wednesday, adding multi-agent capabilities, AI cost analytics, and pre-built workflows aimed at enterprise system modernization.

IBM stock opened at $302.18 on Thursday and was trading down around 2%, sitting within a 52-week range of $212.34 to $332.46.

International Business Machines Corporation, IBM

The headline addition is Bobalytics, a feature designed to monitor AI consumption and resource allocation within development pipelines. The platform now supports parallel, model-native tool calling and uses subagents to manage context and keep costs in check.

IBM packaged the updates into three premium tiers. The IBM Z package targets COBOL and PL/I modernization along with JCL analysis for mainframe environments. The IBM i package brings remote file system integration and tailored workflows. The Java Modernization package covers migration to Java 25, large-scale refactoring, and dependency analysis.

The scope here is not small. IBM cited a survey showing 85% of DevSecOps professionals believe AI has shifted the development bottleneck away from writing code and toward reviewing and validating it.

Results from early adopters back that up. Kevin Sligar, Chief Technical Architect at Jack Henry, said the platform accelerates RPG development workflows and improves code quality. Saireshan Govender, Group CEO of Blue Pearl, said a legacy modernization project originally scoped at nine months with 14 engineers was completed in three days using IBM Bob.

What Analysts Are Saying

Wall Street is broadly positive on IBM heading into earnings. BofA Securities raised its price target to $330 with a Buy rating, projecting Q2 revenue of $18.0 billion and EPS of $3.03. Barclays initiated coverage with an Overweight rating and a $350 target. JPMorgan upgraded the stock to Overweight in June, lifting its target to $291.

Not everyone is on board. KeyCorp downgraded IBM to Sector Weight in June, and HSBC sits at Hold with a $231 target. Of 25 analysts tracked, 16 have a Buy rating and nine have a Hold. The consensus sits at “Moderate Buy” with an average target of $306.47.

IBM’s most recent quarterly results came in ahead of expectations. The company posted EPS of $1.91 against estimates of $1.81, with revenue of $15.92 billion beating the $15.60 billion consensus. Revenue was up 9.5% year over year.

Institutional Activity

On the institutional side, Sumitomo Mitsui Trust Group trimmed its IBM position by 3.8% in Q1, selling around 91,570 units, leaving them with a stake worth approximately $569.2 million. Overall, institutional investors and hedge funds hold 58.96% of IBM.

The company also raised its quarterly dividend to $1.69 per unit, up from $1.68, representing a $6.76 annualized payout and a yield of 2.2%. That keeps IBM’s 30-year dividend growth streak alive.